PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Researchers investigate new technique for diagnosing cardiac conditions

Cardiac quantitative susceptibility mapping successfully visualised iron deposits in patients.

Researchers from King’s College London (KCL) have investigated a new technique for diagnosing and evaluating multiple cardiac conditions that involve excess iron.

The new technique, cardiac quantitative susceptibility mapping (QSM), was used to investigate the build-up of excess iron.

With most serious heart attacks, the potential for blood to leak into the heart muscle is more likely and can form iron deposits that can lead to heart failure.

Despite existing methods for detecting iron build-up in the heart, a variety of other conditions that are associated with heart attacks can affect these methods.

Published in the Journal of Cardiovascular Magnetic Resonance, researchers assessed the accuracy of QSM with a purpose-built susceptibility phantom that contained tubes with a range of gadolinium concentrations, clear, colourless fluid used to make images clearer during an MRI scan.

Researchers then tested QSM in ten health volunteers and five patients with a ST-segment elevation myocardial infarction and suspected intra-myocardial haemorrhage to detect regions of increased susceptibility and iron in vivo.

Results showed that QSM was successfully able to visualise iron deposits and has the potential to improve diagnosis by reducing sensitivity to other conditions.

Additionally, QSM for iron could help researchers explore novel therapies as well as different clinical scenarios.

Researchers suggest further clinical evaluation of the new technique before it can be used in healthcare.

Dr Andrew Tyer, research association, KCL’s School of Biomedical Engineering and Imaging Science, said: “This work takes an important step towards translating QSM to the clinic by characterising its performance in the heart in healthy controls and patients before demonstrating the detection of these iron deposits in patients with heart attacks.”

Dr Pier Giorgio Masci, consultant cardiologist at KCL, said: “This technique will pave the avenue for a more comprehensive, fully quantitative investigation of the ischaemia-reperfusion damage in patients who have suffered a severe heart attack, known as a ST-segment-elevation myocardial infarction.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026